Position history for BAKER BROS. ADVISORS LP's holdings in TSCAN THERAPEUTICS INC
BAKER BROS. ADVISORS LP holds 2.8M shares of TCRX (TSCAN THERAPEUTICS INC), worth $2.8M as of 2026-Q1. TCRX represents 0.0% of BAKER BROS. ADVISORS LP's portfolio.
Current Value
$2.8M
Current Shares
2.8M
Total Value Change
-$13.5M
Total Shares Change
0
Other major holders of TCRX: ADAGE CAPITAL PARTNERS GP, L.L.C., BlackRock Finance, Inc.
Unchanged |
| 2.8M |
0.0% |
| $2.8M |
| 0.0% |
| $1.03 |
0 |
| 2025-Q4 | Unchanged | 2.8M | 0.0% | $2.8M | 0.0% | $1.03 | 0 |
| 2025-Q3 | Unchanged | 2.8M | 0.0% | $5.1M | 0.0% | $1.74 | 0 |
| 2025-Q2 | Unchanged | 2.8M | 0.0% | $4M | 0.0% | $1.40 | 0 |
| 2025-Q1 | Unchanged | 2.8M | 0.0% | $3.8M | 0.0% | $1.35 | 0 |
| 2024-Q4 | Unchanged | 2.8M | 0.0% | $8.5M | 0.1% | $3.00 | 0 |
| 2024-Q3 | Unchanged | 2.8M | 0.0% | $13.9M | 0.1% | $5.04 | 0 |
| 2024-Q2 | Unchanged | 2.8M | 0.0% | $16.3M | 0.2% | $5.85 | 0 |